New anti-tuberculosis drug
U.S. Food & Drug Administration (FDA) has approved a new drug Pretomanid for treating drug-resistant tuberculosis.
Pretomanid is only the third new anti-TB drug approved for use by FDA in more than 40 years.
Pretomanid will be part of the three-drug regimen for drug approval by the European Medicines Agency (EMA).
The duration of treatment for drug-resistant TB can be drastically cut from 18-24 months to just six-nine months when pretomanid drug is used along with two already approved drugs — bedaquiline and linezolid.
India has 24% of MDR-TB cases in the world.
What is tuberculosis (TB)?
It is a disease caused by bacteria that are spread from person to person through the air.
TB usually affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine.
U.S. Food & Drug Administration (FDA) has approved a new drug Pretomanid for treating drug-resistant tuberculosis.
Pretomanid is only the third new anti-TB drug approved for use by FDA in more than 40 years.
Pretomanid will be part of the three-drug regimen for drug approval by the European Medicines Agency (EMA).
The duration of treatment for drug-resistant TB can be drastically cut from 18-24 months to just six-nine months when pretomanid drug is used along with two already approved drugs — bedaquiline and linezolid.
India has 24% of MDR-TB cases in the world.
What is tuberculosis (TB)?
It is a disease caused by bacteria that are spread from person to person through the air.
TB usually affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine.
No comments:
Post a Comment